These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058 [TBL] [Abstract][Full Text] [Related]
9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Liu ID; Willis NS; Craig JC; Hodson EM Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142 [TBL] [Abstract][Full Text] [Related]
10. Preoperative education for hip or knee replacement. McDonald S; Page MJ; Beringer K; Wasiak J; Sprowson A Cochrane Database Syst Rev; 2014 May; 2014(5):CD003526. PubMed ID: 24820247 [TBL] [Abstract][Full Text] [Related]
11. Pathogen-reduced platelets for the prevention of bleeding. Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569 [TBL] [Abstract][Full Text] [Related]
12. Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation? Harmankaya O; Cetin B; Obek A; Seber E Ren Fail; 2002 Sep; 24(5):639-44. PubMed ID: 12380910 [TBL] [Abstract][Full Text] [Related]
13. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients. Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD008516. PubMed ID: 22972122 [TBL] [Abstract][Full Text] [Related]
14. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. dos Santos JP; Loureiro A; Cendoroglo Neto M; Pereira BJ Nephrol Dial Transplant; 1996 Oct; 11(10):2017-22. PubMed ID: 8918716 [TBL] [Abstract][Full Text] [Related]
15. Continuous renal replacement therapy (CRRT) for rhabdomyolysis. Zeng X; Zhang L; Wu T; Fu P Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008566. PubMed ID: 24929959 [TBL] [Abstract][Full Text] [Related]
16. Advance care planning for haemodialysis patients. Lim CE; Ng RW; Cheng NC; Cigolini M; Kwok C; Brennan F Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010737. PubMed ID: 27457661 [TBL] [Abstract][Full Text] [Related]
17. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. Macleod AM; Campbell M; Cody JD; Daly C; Donaldson C; Grant A; Khan I; Rabindranath KS; Vale L; Wallace S Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003234. PubMed ID: 16034894 [TBL] [Abstract][Full Text] [Related]
18. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults. Vale L; Cody J; Wallace S; Daly C; Campbell M; Grant A; Khan I; Donaldson C; Macleod A Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003963. PubMed ID: 15495072 [TBL] [Abstract][Full Text] [Related]
19. The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. Shamshirsaz AA; Kamgar M; Bekheirnia MR; Ayazi F; Hashemi SR; Bouzari N; Habibzadeh MR; Pourzahedgilani N; Broumand V; Shamshirsaz AH; Moradi M; Borghei M; Haghighi NN; Broumand B BMC Nephrol; 2004 Oct; 5():13. PubMed ID: 15469615 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Hinrichsen H; Leimenstoll G; Stegen G; Schrader H; Fölsch UR; Schmidt WE; Gut; 2002 Sep; 51(3):429-33. PubMed ID: 12171969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]